489 related articles for article (PubMed ID: 27578609)
1. Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.
Liu Q; Liu Q; Yi J; Liang K; Liu T; Roland KL; Jiang Y; Kong Q
Int J Med Microbiol; 2016 Dec; 306(8):697-706. PubMed ID: 27578609
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge.
Liu Q; Liu Q; Yi J; Liang K; Hu B; Zhang X; Curtiss R; Kong Q
Sci Rep; 2016 Oct; 6():34776. PubMed ID: 27698383
[TBL] [Abstract][Full Text] [Related]
3. Flagellin-deficient outer membrane vesicles as adjuvant induce cross-protection of Salmonella Typhimurium outer membrane proteins against infection by heterologous Salmonella serotypes.
Liu Q; Tan K; Yuan J; Song K; Li R; Huang X; Liu Q
Int J Med Microbiol; 2018 Oct; 308(7):796-802. PubMed ID: 29970302
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and Cross-Protective Efficacy Induced by Outer Membrane Proteins from Salmonella Typhimurium Mutants with Truncated LPS in Mice.
Liu Q; Liu Q; Zhao X; Liu T; Yi J; Liang K; Kong Q
Int J Mol Sci; 2016 Mar; 17(3):416. PubMed ID: 27011167
[TBL] [Abstract][Full Text] [Related]
5. Outer Membrane Vesicles Derived from
Liu Q; Yi J; Liang K; Zhang X; Liu Q
J Microbiol Biotechnol; 2017 Aug; 27(8):1519-1528. PubMed ID: 28539041
[TBL] [Abstract][Full Text] [Related]
6. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
[TBL] [Abstract][Full Text] [Related]
7. Salmonella Choleraesuis outer membrane vesicles: Proteomics and immunogenicity.
Liu Q; Yi J; Liang K; Zhang X; Liu Q
J Basic Microbiol; 2017 Oct; 57(10):852-861. PubMed ID: 28745825
[TBL] [Abstract][Full Text] [Related]
8. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.
Li P; Liu Q; Huang C; Zhao X; Roland KL; Kong Q
Vaccine; 2017 May; 35(21):2862-2869. PubMed ID: 28412074
[TBL] [Abstract][Full Text] [Related]
9. Protective Immunity Elicited by Oral Immunization of Mice with
Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
[TBL] [Abstract][Full Text] [Related]
10. SipD and IpaD induce a cross-protection against Shigella and Salmonella infections.
Jneid B; Rouaix A; Féraudet-Tarisse C; Simon S
PLoS Negl Trop Dis; 2020 May; 14(5):e0008326. PubMed ID: 32463817
[TBL] [Abstract][Full Text] [Related]
11. Two Novel
Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
[TBL] [Abstract][Full Text] [Related]
12. Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.
Kong Q; Yang J; Liu Q; Alamuri P; Roland KL; Curtiss R
Infect Immun; 2011 Oct; 79(10):4227-39. PubMed ID: 21768282
[TBL] [Abstract][Full Text] [Related]
13. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
[TBL] [Abstract][Full Text] [Related]
14. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
15. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF
mBio; 2018 Mar; 9(2):. PubMed ID: 29511082
[TBL] [Abstract][Full Text] [Related]
16. Immunization With Outer Membrane Vesicles Derived From Major Outer Membrane Protein-Deficient
Chen Y; Jie K; Li B; Yu H; Ruan H; Wu J; Huang X; Liu Q
Front Microbiol; 2020; 11():588952. PubMed ID: 33329465
[TBL] [Abstract][Full Text] [Related]
17. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.
Tennant SM; Wang JY; Galen JE; Simon R; Pasetti MF; Gat O; Levine MM
Infect Immun; 2011 Oct; 79(10):4175-85. PubMed ID: 21807911
[TBL] [Abstract][Full Text] [Related]
18. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
[TBL] [Abstract][Full Text] [Related]
19. Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
Zhao X; Liang S; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Yang Q; Wu Y; Zhang S; Zhang L; Liu Y; Yu Y; Cheng A
Vaccine; 2018 Aug; 36(33):5010-5019. PubMed ID: 30017143
[TBL] [Abstract][Full Text] [Related]
20. Deletions in
Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
